Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry

BACKGROUND: Residual risk of ischemic stroke despite anticoagulation in patients with atrial fibrillation (AF) represents a significant clinical issue that remains unaddressed. We aimed to evaluate the incidence and risk factors for residual adverse events in AF. METHODS AND RESULTS: Using data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wern Yew, Lane, Deirdre A., Gupta, Dhiraj, Huisman, Menno V., Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375480/
https://www.ncbi.nlm.nih.gov/pubmed/35876418
http://dx.doi.org/10.1161/JAHA.122.026410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375480/
https://www.ncbi.nlm.nih.gov/pubmed/35876418
http://dx.doi.org/10.1161/JAHA.122.026410

Ejemplares similares